MOORE MEDICAL CORP
3/A, 2000-03-30
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: OLD STONE CORP, NT 10-K, 2000-03-30
Next: ORBIT INTERNATIONAL CORP, 10-K, 2000-03-30



<PAGE>

===============================================================================

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.

                                                /------------------------------/
                                                /        OMB APPROVAL          /
                                                /------------------------------/
                                          \     / OMB Number:        1235-0104 /
EDIT OR DELETE AS NECESSARY----------------     / Expires:  September 30, 1998 /
                                          /     / Estimated average burden     /
                                                / hours per response...... 0.5 /
                                                /------------------------------/


+----------+
| FORM 3/A |        U.S. SECURITIES AND EXCHANGE COMMISSION
+----------+                WASHINGTON, D.C. 20549

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
      Section 17(a) of the Public Utility Holding Company Act of 1935 or
              Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)

- --------------------------------------------------------------------------------
1.  Name and Address of Reporting Person*

     Brody                        Christopher                         W.
    ----------------------------------------------------------------------------
        (Last)                      (First)                        (Middle)

      c/o Vantage Partners, LLC     610 Fifth Ave.                 7th Floor
    ----------------------------------------------------------------------------
                                   (Street)

      New York                       NY                              10020
    ----------------------------------------------------------------------------
        (City)                      (State)                           (Zip)


2.  Date of Event Requiring Statement (Month/Day/Year)               03/01/00
                                                                  --------------

3.  IRS Identification Number of Reporting Person if an Entity
    (Voluntary)
                --------------

4.  Issuer Name and Ticker or Trading Symbol  Moore Medical Corp.
                                             -----------------------------------

5.  Relationship of Reporting Person(s) to Issuer (Check all applicable)

    [X] Director    [_] Officer             [_] 10% Owner    [_] Other
                        (give title below)                       (specify below)


    ----------------------------------------------------------------------------

6.  If Amendment, Date of Original (Month/Day/Year)              03/02/00
                                                    ----------------------------
7.  Individual or Joint Group Filing (Check Applicable Line)

    __X__ Form Filed by One Reporting Person
    _____ Form filed by More than One Reporting Person

             TABLE I--NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED

<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------
1. Title           2. Amount of         3. Ownership Form:  4. Nature of
   of                 Securities Bene-     Direct (D) or       Indirect Bene-
   Security           ficially Owned       Indirect (I)        ficial Ownership
   (Instr. 4)         (Instr. 4)           (Instr. 5)          (Instr. 5)
- --------------------------------------------------------------------------------
<S>               <C>                   <C>                 <C>

- --------------------------------------------------------------------------------
 Common Stock         26,600                  D
- --------------------------------------------------------------------------------
 Common Stock         50,000                  I                  (1)
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.


<PAGE>

FORM 3 (Continued)

              TABLE II--DERIVATIVE SECURITIES BENEFICIALLY OWNED
        (e.g., puts, calls, warrants, options, convertible securities)

<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------
 1. Title of Derivative        2. Date Exer-    3. Title and Amount of Securities   4. Conversion   5. Ownership   6. Nature of In-
    Security (Instr. 4)           cisable and      Underlying Derivative Security      or              Form of        direct Bene-
                                  Expiration       (Instr. 4)                          Exercise        Derivative     ficial
                                  Date                                                 Price           Security:      Ownership
                                  (Month/Day/                                          of              Direct (D)     (Instr. 5)
                                  Year)                                                Derivative      or In-
                              ----------------------------------------------------     Security        direct (I)
                               Date      Expira-                        Amount or                      (Instr. 5)
                               Exer-     tion            Title          Number of
                               cisable   Date                           Shares
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                            <C>       <C>    <C>                     <C>         <C>             <C>            <C>

- ------------------------------------------------------------------------------------------------------------------------------------
    ---                         ---      ---    ---                     ---         ---             ---           ---
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.

(1) The shares are held by Vantage Venture Partners, LP; Mr. Brody is Chairman
    of its general partner, Vantage Partners, LLC. Mr. Brody has a partial
    indirect interest in Vantage Venture Partners, LP.

                                                                   03/23/00
                              -------------------------------  -----------------
                              **Signature of Reporting Person        Date


     * If the form is filed by more than one reported person, see Instruction
       5(b)(v).

    ** Intentional misstatements or omissions of facts constitute Federal
       Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:  File three copies of this Form, one of which must be manually signed.
       If space is insufficient, See Instruction 6 for procedure.







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission